Hospitals | October 29, 2021
Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
Emkay Research expects Q2FY22 to be a normalised quarter for pharma companies that it tracks. A summary of the report
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
Subscribe To Our Newsletter & Stay Updated
